This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
public health | 292 |
infectious diseases | 279 |
infectious disease | 203 |
escherichia coli | 185 |
pathogen avoidance | 152 |
immune system | 145 |
immune responses | 141 |
immune response | 136 |
human pathogens | 112 |
enteric pathogens | 99 |
respiratory syndrome | 97 |
spa scores | 93 |
pathogen transmission | 91 |
ebola virus | 86 |
acute respiratory | 85 |
airborne pathogen | 84 |
respiratory tract | 82 |
drinking water | 80 |
respiratory disease | 79 |
infectious agents | 78 |
yersinia pestis | 78 |
indoor air | 75 |
genome sequencing | 73 |
vaccine development | 72 |
united states | 72 |
severe acute | 72 |
landscape genetics | 71 |
bacterial pathogens | 70 |
spa scale | 70 |
plant pathogens | 69 |
respiratory pathogens | 65 |
influenza virus | 64 |
emerging pathogens | 63 |
fecal contamination | 63 |
cord uid | 61 |
doc id | 61 |
ventilation rate | 61 |
host shifts | 61 |
antifungal activity | 60 |
disease emergence | 58 |
human populations | 57 |
pathogen genomics | 57 |
positive selection | 56 |
host species | 56 |
emerging infectious | 55 |
pathogen threat | 55 |
pathogenic bacteria | 54 |
risk assessment | 53 |
airborne transmission | 53 |
innate immune | 52 |
host immune | 52 |
infection risk | 52 |
pathogen species | 52 |
wastewater treatment | 51 |
foodborne pathogens | 50 |
risk factors | 50 |
water quality | 50 |
gene expression | 50 |
world health | 49 |
nucleic acid | 49 |
wide range | 48 |
disease outbreaks | 46 |
viral pathogens | 46 |
human health | 46 |
constructed wetlands | 46 |
airborne pathogens | 46 |
rna viruses | 45 |
landscape genetic | 45 |
waterborne pathogens | 45 |
pathogen exposure | 45 |
systematic review | 44 |
host defense | 44 |
health organization | 44 |
live attenuated | 44 |
zoonotic pathogens | 43 |
pathogen concentration | 43 |
whole genome | 43 |
th century | 43 |
salmonella enterica | 42 |
irrigation water | 42 |
human population | 42 |
virulence factors | 41 |
fresh produce | 41 |
antimicrobial resistance | 41 |
pathogen reduction | 41 |
adaptive immune | 40 |
infection control | 39 |
animal health | 39 |
pathogens may | 39 |
enteric pathogen | 39 |
pathogen detection | 38 |
disease control | 38 |
cell surface | 38 |
species transmission | 38 |
may also | 38 |
staphylococcus aureus | 38 |
pathogen interactions | 37 |
pathogen inactivation | 37 |
host range | 37 |
one health | 36 |
genetic diversity | 36 |
exposure assessments | 36 |
species richness | 36 |
bovine respiratory | 36 |
human genome | 36 |
disease surveillance | 36 |
environmental samples | 36 |
infl uenza | 35 |
climate change | 34 |
specific pathogens | 34 |
mycobacterium tuberculosis | 34 |
time pcr | 34 |
listeria monocytogenes | 34 |
human transmission | 33 |
food safety | 33 |
environmental conditions | 32 |
high levels | 32 |
innate immunity | 31 |
data sharing | 31 |
host cells | 31 |
host cell | 31 |
amino acid | 31 |
host population | 30 |
virus infection | 30 |
clinical trials | 30 |
positively selected | 30 |
disease transmission | 30 |
pathogen dispersion | 29 |
chronic fatigue | 29 |
developing countries | 29 |
ultraviolet light | 29 |
sequence data | 29 |
pathogen genomes | 29 |
generation sequencing | 28 |
antimicrobial activity | 28 |
syndrome coronavirus | 28 |
zika virus | 28 |
syncytial virus | 28 |
recent years | 28 |
control measures | 28 |
pathogen removal | 28 |
nucleic acids | 28 |
yellow fever | 28 |
fatigue syndrome | 28 |
syndromic surveillance | 28 |
cell wall | 28 |
wild primates | 28 |
respiratory syncytial | 27 |
certification programs | 27 |
infected individuals | 27 |
viral infections | 27 |
platelet concentrates | 27 |
pathogen spillover | 27 |
plasmodium falciparum | 27 |
large number | 27 |
protein ligand | 27 |
multiple pathogens | 27 |
obese target | 26 |
time series | 26 |
cell responses | 26 |
salmonella typhimurium | 26 |
animal pathogens | 26 |
virus transmission | 26 |
bacterial species | 26 |
essential oils | 26 |
fever virus | 26 |
disease risk | 26 |
genome sequence | 26 |
epithelial cells | 26 |
streptococcus pneumoniae | 25 |
endophytic fungus | 25 |
immunodeficiency virus | 25 |
sequencing technologies | 25 |
human disease | 25 |
antibody responses | 25 |
phylogenetic risk | 25 |
genomic data | 25 |
sexually transmitted | 25 |
emerging viruses | 25 |
many cases | 25 |
selective pressure | 24 |
drug resistance | 24 |
enterica serovar | 24 |
air pollution | 24 |
protein microarrays | 24 |
lyme disease | 24 |
relative humidity | 24 |
vaccine vectors | 24 |
immune cells | 24 |
botrytis cinerea | 24 |
red blood | 24 |
west africa | 24 |
health care | 24 |
plant pathogenic | 24 |
respiratory pathogen | 24 |
transmission dynamics | 23 |
human body | 23 |
human pathogen | 23 |
sexual transmission | 23 |
genetic variation | 23 |
human microbiome | 23 |
lower respiratory | 23 |
chain reaction | 23 |
bovine viral | 23 |
polymerase chain | 23 |
blood cells | 23 |
airborne infection | 23 |
also known | 23 |
ancient pathogen | 23 |
dna microarrays | 23 |
global burden | 23 |
population structure | 23 |
inflammatory response | 23 |
hiv infection | 23 |
rapid detection | 23 |
future research | 23 |
lactic acid | 23 |
fluid dynamics | 23 |
high throughput | 22 |
probiotic bacteria | 22 |
respiratory infections | 22 |
selected sites | 22 |
hong kong | 22 |
pathogen spread | 22 |
ventilation system | 22 |
depressive symptoms | 22 |
protein ligands | 22 |
transmission events | 22 |
new vaccine | 22 |
acquired pneumonia | 22 |
case study | 22 |
dna vaccines | 22 |
attenuated vaccines | 21 |
middle east | 21 |
human host | 21 |
organic compounds | 21 |
innate leukocytes | 21 |
tracer gas | 21 |
installing partitions | 21 |
human immunodeficiency | 21 |
direct contact | 21 |
constructed wetland | 21 |
fusarium oxysporum | 21 |
avian influenza | 21 |
west nile | 21 |
gut microbiome | 21 |
pathogen survival | 21 |
domestic animal | 21 |
new host | 21 |
surveillance system | 21 |
disease ecology | 21 |
phylogenetic analysis | 21 |
closely related | 21 |
causative agent | 21 |
antibiotic resistance | 21 |
black death | 21 |
opportunistic pathogens | 21 |
pathogen surveillance | 21 |
surface proteins | 20 |
important role | 20 |
vaccinia virus | 20 |
genetic data | 20 |
additional file | 20 |
domestic animals | 20 |
pathogenic viruses | 20 |
upper respiratory | 20 |
foodborne illness | 20 |
diarrhea virus | 20 |
genomic epidemiology | 20 |
intracellular pathogens | 20 |
natural selection | 20 |
pathogen patients | 20 |
phase i | 20 |
indicator bacteria | 20 |
human infectious | 20 |
animal populations | 20 |
ancient dna | 20 |
dual pathogens | 20 |
surface water | 20 |
throughput sequencing | 20 |
surface plasmon | 20 |
viral diarrhea | 20 |
pseudomonas aeruginosa | 20 |
tract infections | 20 |
population density | 20 |
years ago | 20 |
widely used | 19 |
infectious agent | 19 |
resistance genes | 19 |
water sources | 19 |
chronic diseases | 19 |
fecal coliforms | 19 |
secondary metabolites | 19 |
mass spectrometry | 19 |
nervous system | 19 |
gene products | 19 |
endophytic fungi | 19 |
emerging diseases | 19 |
cfu ml | 19 |
gastrointestinal tract | 19 |
adaptive immunity | 19 |
better understanding | 19 |
surface protein | 19 |
real time | 19 |
aquatic plants | 19 |
exposure assessment | 19 |
molecular methods | 19 |
air decontamination | 19 |
east respiratory | 19 |
host factors | 19 |
volatile organic | 19 |
plasmon resonance | 19 |
zoonotic infections | 19 |
detection methods | 19 |
recent studies | 19 |
young children | 19 |
several studies | 18 |
major depression | 18 |
pathogen counts | 18 |
health surveillance | 18 |
examined whether | 18 |
protein microarray | 18 |
like receptors | 18 |
barr virus | 18 |
water samples | 18 |
air quality | 18 |
sars coronavirus | 18 |
seasonal terms | 18 |
genes involved | 18 |
dna sequencing | 18 |
persistently infected | 18 |
enteric bacteria | 18 |
evolutionary history | 18 |
molecular techniques | 18 |
infection prevention | 18 |
novel pathogens | 18 |
global health | 18 |
pathogenic fungi | 18 |
airborne spread | 18 |
management practices | 18 |
rotavirus vaccine | 18 |
reemerging pathogens | 18 |
health professionals | 18 |
disease prevention | 18 |
gene flow | 18 |
new world | 17 |
pathogen source | 17 |
muscodor albus | 17 |
natural killer | 17 |
valley fever | 17 |
data set | 17 |
endophytic actinomycetes | 17 |
clostridium difficile | 17 |
new pathogens | 17 |
source tracking | 17 |
rift valley | 17 |
plant growth | 17 |
pathogen strain | 17 |
extracellular protein | 17 |
reservoir hosts | 17 |
pathogen interaction | 17 |
immune function | 17 |
barrier function | 17 |
serovar typhimurium | 17 |
pathogen prevalence | 17 |
environmental surfaces | 17 |
human cells | 17 |
vaccine safety | 17 |
plant extracts | 17 |
microbiome dysbiosis | 17 |
health risk | 17 |
clinical trial | 17 |
infect humans | 17 |
reduction technology | 17 |
wild animals | 17 |
viral infection | 17 |
germ aversion | 17 |
dna microarray | 17 |
many pathogens | 17 |
rhizoctonia solani | 17 |
aversive reactions | 17 |
microbial pathogens | 17 |
adaptive response | 17 |
plant pathogen | 17 |
cell culture | 17 |
host shift | 17 |
outbreak investigations | 17 |
social biases | 16 |
biological control | 16 |
tissue culture | 16 |
cfd simulation | 16 |
phase iii | 16 |
microarray technology | 16 |
microbial risk | 16 |
borne pathogens | 16 |
crispr cas | 16 |
avoidance motives | 16 |
fungal pathogens | 16 |
mutation rates | 16 |
specific pathogen | 16 |
different types | 16 |
surveillance systems | 16 |
campylobacter jejuni | 16 |
virus disease | 16 |
nipah virus | 16 |
molecular tools | 16 |
life cycle | 16 |
reactions toward | 16 |
disease resistance | 16 |
increased risk | 16 |
infected individual | 16 |
central nervous | 16 |
primate species | 16 |
enveloped viruses | 16 |
intervention strategies | 16 |
bacterial infections | 16 |
virus type | 16 |
genetic structure | 16 |
will also | 16 |
immune activation | 16 |
transmitted pathogens | 15 |
streptomyces sp | 15 |
plasma membrane | 15 |
cell death | 15 |
infectious pathogens | 15 |
innate response | 15 |
treatment processes | 15 |
recent advances | 15 |
high risk | 15 |
water treatment | 15 |
outlet locations | 15 |
plant roots | 15 |
host plant | 15 |
chronic inflammation | 15 |
respiratory system | 15 |
fecal indicator | 15 |
disease burden | 15 |
commercially available | 15 |
produce contamination | 15 |
borne transmission | 15 |
based methods | 15 |
disease outbreak | 15 |
old world | 15 |
laboratory submissions | 15 |
bacillus anthracis | 15 |
authors declare | 15 |
mammalian cells | 15 |
microbial communities | 15 |
clinical samples | 15 |
novel viruses | 15 |
arbuscular mycorrhizal | 15 |
salmonella spp | 15 |
salmonella enteritidis | 15 |
transmission pathways | 15 |
viral pathogen | 15 |
dilution effect | 15 |
may result | 15 |
bronze age | 15 |
trait pathogen | 15 |
bubonic plague | 15 |
risk alleles | 15 |
antigen discovery | 15 |
mosaic virus | 15 |
flow constructed | 15 |
lactobacillus casei | 15 |
like receptor | 15 |
increased inflammation | 15 |
source bed | 15 |
antigen receptor | 14 |
human immune | 14 |
health practice | 14 |
data sets | 14 |
communication engineering | 14 |
novel coronavirus | 14 |
evolutionary analysis | 14 |
respiratory viruses | 14 |
defense mechanisms | 14 |
lassa virus | 14 |
hemorrhagic fever | 14 |
individual differences | 14 |
multiplex pcr | 14 |
age group | 14 |
pathogen groups | 14 |
vaccine vector | 14 |
cause disease | 14 |
pathogen dna | 14 |
immunocompromised patients | 14 |
nile virus | 14 |
virulence factor | 14 |
bronchoalveolar lavage | 14 |
host interactions | 14 |
natural products | 14 |
blood components | 14 |
deep sequencing | 14 |
health benefits | 14 |
helicobacter pylori | 14 |
whole blood | 14 |
weather variables | 14 |
pathogenic microorganisms | 14 |
neutralizing antibodies | 14 |
new vaccines | 14 |
environmental health | 14 |
pathogen defense | 14 |
increased ventilation | 14 |
dn ds | 14 |
health outcomes | 14 |
targeted pathogens | 14 |
commonly used | 14 |
acute phase | 14 |
animal models | 14 |
adjacent beds | 14 |
species diversity | 14 |
competing interests | 14 |
given pathogen | 14 |
ambient temperature | 14 |
high affinity | 14 |
life history | 14 |
zoonotic pathogen | 14 |
pathogen contamination | 14 |
borne diseases | 14 |
control foodborne | 14 |
myalgic encephalomyelitis | 14 |
acid bacteria | 14 |
pathogen identification | 14 |
food production | 13 |
oral transmission | 13 |
field studies | 13 |
bacterial infection | 13 |
control strategies | 13 |
pathogen shedding | 13 |
crop loss | 13 |
equine encephalitis | 13 |
mhc class | 13 |
borrelia burgdorferi | 13 |
recipient host | 13 |
experimental manipulations | 13 |
zoonotic viruses | 13 |
reservoir host | 13 |
pathogens will | 13 |
contact rates | 13 |
microbial community | 13 |
lassa fever | 13 |
surface receptor | 13 |
high rates | 13 |
natural infection | 13 |
antimicrobial peptides | 13 |
protein interactions | 13 |
based biosensors | 13 |
humoral immune | 13 |
saharan africa | 13 |
viral respiratory | 13 |
significant differences | 13 |
one pathogen | 13 |
outbreak detection | 13 |
early warning | 13 |
pathogen disgust | 13 |
microbial contamination | 13 |
among children | 13 |
pathogen sequence | 13 |
protein interaction | 13 |
viral mono | 13 |
united kingdom | 13 |
contaminated water | 13 |
cohort study | 13 |
measles virus | 13 |
antigen presentation | 13 |
situational pathogen | 13 |
bacterial contamination | 13 |
human pathogenic | 13 |
host immunity | 13 |
hiv aids | 13 |
bacterial pathogen | 13 |
refl ect | 13 |
north america | 13 |
income countries | 13 |
intercept tm | 13 |
recent developments | 13 |
wide variety | 13 |
land use | 13 |
influenza viruses | 13 |
lattice boltzmann | 13 |
genetic recombination | 12 |
animal model | 12 |
spillover risk | 12 |
environmental exposure | 12 |
cfd method | 12 |
disease spread | 12 |
surface waters | 12 |
causal agent | 12 |
deaths due | 12 |
dengue virus | 12 |
laden droplets | 12 |
pathogen community | 12 |
species pathogen | 12 |
human society | 12 |
host specificity | 12 |
fungal cell | 12 |
foodborne disease | 12 |
raw materials | 12 |
emerging pathogen | 12 |
two types | 12 |
proinflammatory cytokines | 12 |
treatment systems | 12 |
vaccine efficacy | 12 |
plant material | 12 |
bioactive compounds | 12 |
potential pathogens | 12 |
least one | 12 |
dendritic cells | 12 |
health agencies | 12 |
transmission mechanisms | 12 |
significantly reduced | 12 |
infected host | 12 |
randomized controlled | 12 |
central africa | 12 |
organic wastes | 12 |
quantitative pcr | 12 |
recipient hosts | 12 |
experimental manipulation | 12 |
clinical practice | 12 |
currently available | 12 |
environmental factors | 12 |
effector cells | 12 |
will likely | 12 |
health status | 12 |
preclinical studies | 12 |
water distribution | 12 |
among humans | 12 |
single nucleotide | 12 |
cell line | 12 |
human infection | 12 |
antibody response | 12 |
less likely | 12 |
ad hoc | 12 |
naturally occurring | 12 |
mutation rate | 12 |
emerging disease | 12 |
zoonotic diseases | 12 |
total number | 12 |
second protein | 12 |
based detection | 12 |
blood cell | 12 |
simultaneous detection | 12 |
selective pressures | 12 |
pathogen virulence | 12 |
molecular evolution | 12 |
computational fluid | 12 |
genetic material | 12 |
dna vaccine | 12 |
situationally activated | 12 |
airborne bacteria | 12 |
vaccine candidate | 12 |
pathogens like | 12 |
phytopathogenic fungi | 12 |
quantitative microbial | 12 |
infecting humans | 12 |
vaccination programs | 12 |
respiratory infection | 12 |
red queen | 11 |
high removal | 11 |
broad spectrum | 11 |
environmental water | 11 |
added value | 11 |
molecular patterns | 11 |
yersinia pseudotuberculosis | 11 |
viral surface | 11 |
vaccines based | 11 |
complete genome | 11 |
depressive disorder | 11 |
comparative genomics | 11 |
plant species | 11 |
fecal coliform | 11 |
pathogen genetic | 11 |
high level | 11 |
class i | 11 |
microbial genomes | 11 |
vegetative bacteria | 11 |
animal species | 11 |
risk assessments | 11 |
enterohemorrhagic escherichia | 11 |
false positive | 11 |
genome sequences | 11 |
another example | 11 |
psychosocial stress | 11 |
epithelial barrier | 11 |
vaccine candidates | 11 |
haemophilus influenzae | 11 |
pathogen control | 11 |
population centers | 11 |
controlled trial | 11 |
occupational health | 11 |
molecular biology | 11 |
bacterial genomes | 11 |
mixed infections | 11 |
airborne particles | 11 |
domestic wastewater | 11 |
shiga toxin | 11 |
human diseases | 11 |
methods used | 11 |
health risks | 11 |
major depressive | 11 |
immune cell | 11 |
diarrhea deaths | 11 |
transmission amplifiers | 11 |
pathogen may | 11 |
air supply | 11 |
host bacteria | 11 |
clinical microbiology | 11 |
pathogen genome | 11 |
oral route | 11 |
biologically active | 11 |
infected cells | 11 |
virus genomes | 11 |
antigen receptors | 11 |
perceived infectability | 11 |
human evolution | 11 |
rrna gene | 11 |
haploid cell | 11 |
natural ventilation | 11 |
adaptive leukocytes | 11 |
phage display | 11 |
reactive protein | 11 |
microbial species | 11 |
membrane protein | 11 |
oxidative stress | 11 |
sustained human | 11 |
control study | 11 |
nk cell | 11 |
first step | 11 |
natural immunity | 11 |
behavioral responses | 11 |
community similarity | 11 |
close contact | 10 |
host populations | 10 |
outbreak response | 10 |
immune protection | 10 |
significant reduction | 10 |
chikungunya virus | 10 |
participants completed | 10 |
technological advances | 10 |
frequently used | 10 |
genes encoding | 10 |
enteric infections | 10 |
body fluids | 10 |
inaktivierung von | 10 |
clinical diagnosis | 10 |
inflammatory responses | 10 |
droplet nuclei | 10 |
chronic pathogen | 10 |
antimicrobial compounds | 10 |
cryptosporidium parvum | 10 |
clinical disease | 10 |
disease caused | 10 |
genome analysis | 10 |
pathogen proteins | 10 |
white blood | 10 |
zoonotic disease | 10 |
genetic studies | 10 |
treatment plants | 10 |
immune defenses | 10 |
produce safety | 10 |
antimicrobial agents | 10 |
cellular receptor | 10 |
high virulence | 10 |
seasonal influenza | 10 |
st century | 10 |
neisseria meningitidis | 10 |
great apes | 10 |
indoor environments | 10 |
rights reserved | 10 |
inpatient studies | 10 |
individual patient | 10 |
encephalomyelitis chronic | 10 |
dna viruses | 10 |
current status | 10 |
whether spa | 10 |
index case | 10 |
pathogen sharing | 10 |
microbial source | 10 |
vibrio cholerae | 10 |
adaptive responses | 10 |
safety concerns | 10 |
organic acids | 10 |
model fit | 10 |
spillover events | 10 |
resistant staphylococcus | 10 |
subsurface flow | 10 |
disease progression | 10 |
next generation | 10 |
sickness behavior | 10 |
recent study | 10 |
francisella tularensis | 10 |
rural bangladesh | 10 |
population growth | 10 |
infectious bioaerosols | 10 |
leaf spot | 10 |
membrane proteins | 10 |
pandemic influenza | 10 |
major role | 10 |
protective immune | 10 |
pregnant women | 10 |
acid extraction | 10 |
modern day | 10 |
emerging zoonotic | 10 |
genomic surveillance | 10 |
subunit vaccines | 10 |
viral vectors | 10 |
experimental conditions | 10 |
previously unknown | 10 |
human viruses | 10 |
high mutation | 10 |
pathogen communities | 10 |
target dna | 10 |
organic solvents | 10 |
aerobiology chamber | 10 |
digital epidemiology | 10 |
coliform bacteria | 10 |
risks associated | 10 |
control practitioners | 10 |
pathogen diversity | 10 |
clostridium perfringens | 10 |
disease process | 10 |
based vaccine | 10 |
peripheral blood | 10 |
pathogens using | 10 |
infection may | 10 |
farm animals | 10 |
inflammatory disease | 10 |
foodborne diseases | 10 |
pathogens associated | 10 |
new infections | 10 |
disease detection | 10 |
vast majority | 10 |
stranded rna | 10 |
health activities | 10 |
high sensitivity | 10 |
inflammatory biomarkers | 10 |
final product | 10 |
antifungal activities | 10 |
novel human | 10 |
bacterial mono | 10 |
sample collection | 10 |
cell receptor | 10 |
even though | 10 |
airborne infections | 10 |
food chain | 10 |
environmental variables | 10 |
european union | 10 |
higher levels | 10 |
different environmental | 10 |
monoclonal antibodies | 10 |
breast milk | 10 |
adenovirus vectors | 10 |
major human | 10 |
activated pathogen | 10 |
pathogen pairs | 10 |
immune systems | 10 |
effective vaccines | 10 |
receptor binding | 10 |
animal diseases | 10 |
comparative study | 10 |
disease research | 10 |
incubation period | 10 |
past decade | 10 |
general population | 9 |
probiotic strains | 9 |
virus vaccine | 9 |
large droplets | 9 |
recombinant probiotic | 9 |
clinical metagenomics | 9 |
situ hybridization | 9 |
simulation model | 9 |
also included | 9 |
relatively low | 9 |
root rot | 9 |
two pathogens | 9 |
onward transmission | 9 |
might also | 9 |
campylobacter spp | 9 |
will require | 9 |
every year | 9 |
pathogens causing | 9 |
resistant bacteria | 9 |
mean proportion | 9 |
feedlot cattle | 9 |
many countries | 9 |
measurement error | 9 |
airborne survival | 9 |
acquired immune | 9 |
surveillance data | 9 |
genetic variability | 9 |
broad range | 9 |
disease study | 9 |
simulation results | 9 |
infected animals | 9 |
systematic analysis | 9 |
quality monitoring | 9 |
directly transmitted | 9 |
sewage sludge | 9 |
host types | 9 |
cytokine activation | 9 |
intestinal barrier | 9 |
may increase | 9 |
last decade | 9 |
plague pandemic | 9 |
removal efficiency | 9 |
research teams | 9 |
molecular beacons | 9 |
may provide | 9 |
pcr assay | 9 |
will need | 9 |
virus entry | 9 |
wildlife populations | 9 |
antifungal compounds | 9 |
causative agents | 9 |
forecasting system | 9 |
certification standard | 9 |
intestinal epithelial | 9 |
depressed individuals | 9 |
regulatory authorities | 9 |
molecular mechanisms | 9 |
increasing number | 9 |
negative bacteria | 9 |
protective effect | 9 |
lactobacillus rhamnosus | 9 |
rapid identification | 9 |
dna damage | 9 |
disease informatics | 9 |
blood supply | 9 |
associated pneumonia | 9 |
microbiological quality | 9 |
new approaches | 9 |
previously unrecognized | 9 |
gut microbiota | 9 |
target cell | 9 |
mouth disease | 9 |
municipal wastewater | 9 |
disease agents | 9 |
population size | 9 |
well known | 9 |
factors affecting | 9 |
cell types | 9 |
susceptible hosts | 9 |
data providers | 9 |
sars epidemic | 9 |
infectious causation | 9 |
biological activity | 9 |
nk cells | 9 |
dna sequences | 9 |
environmental contamination | 9 |
external exposure | 9 |
us centers | 9 |
global trends | 9 |
community structure | 9 |
initial infection | 9 |
raw material | 9 |
oie list | 9 |
pathogens detected | 9 |
sequence information | 9 |
psychological stress | 9 |
pathogen evolution | 9 |
arms race | 9 |
identify novel | 9 |
transmission within | 9 |
persistent infection | 9 |
past years | 9 |
one study | 9 |
healthy subjects | 9 |
leading cause | 9 |
mortality rates | 9 |
healthy individuals | 9 |
data collection | 9 |
transmission among | 9 |
viral diversity | 9 |
platelets treated | 9 |
epidemiological studies | 9 |
studies suggest | 9 |
animal reservoirs | 9 |
molecular mimicry | 9 |
high density | 9 |
medicinal plant | 9 |
mean proportions | 9 |
extracellular host | 9 |
virus particles | 9 |
microbiome communities | 9 |
pathogen concentrations | 9 |
effect size | 9 |
development efforts | 9 |
herpes simplex | 9 |
past exposure | 9 |
amino acids | 9 |
pseudomonas syringae | 9 |
sensitive detection | 9 |
defense responses | 9 |
may help | 9 |
across human | 9 |
using riboflavin | 9 |
indicator organisms | 9 |
pathogens involved | 9 |
using cfd | 9 |
mathematical models | 9 |
aerosol transmission | 9 |
pathogen infection | 9 |
data end | 9 |
natural history | 9 |
examples include | 9 |
protein array | 9 |
ecological niche | 9 |
intestinal microbiota | 9 |
right now | 9 |
much lower | 9 |
many years | 9 |
microbial world | 9 |
metagenomic sequencing | 9 |
lymph nodes | 9 |
decontamination technologies | 9 |
organic matter | 9 |
pathogen infections | 9 |
viral genome | 9 |
another study | 9 |
viral particles | 9 |
pathogen activity | 9 |
white targets | 9 |
study found | 9 |
microarray analysis | 9 |
outlet location | 9 |
host defenses | 9 |
may affect | 9 |
wildlife species | 9 |
new technologies | 9 |
highly pathogenic | 8 |
plant defense | 8 |
nonhuman primates | 8 |
human blood | 8 |
will continue | 8 |
inflammatory conditions | 8 |
transferrin receptor | 8 |
rheumatoid arthritis | 8 |
cryptosporidium spp | 8 |
encephalitis virus | 8 |
waterborne diseases | 8 |
zoonotic transmission | 8 |
pathogen emergence | 8 |
digital pathogen | 8 |
diagnostic test | 8 |
available data | 8 |
different pathogens | 8 |
vertical flow | 8 |
biocontrol agents | 8 |
plant protection | 8 |
internal exposure | 8 |
soil type | 8 |
drug targets | 8 |
future studies | 8 |
infectious dose | 8 |
poorly understood | 8 |
population genetic | 8 |
sequencing technology | 8 |
health significance | 8 |
two species | 8 |
cell receptors | 8 |
based forecasting | 8 |
viral rna | 8 |
disease management | 8 |
tohuman transmission | 8 |
several years | 8 |
diseases caused | 8 |
psychological processes | 8 |
rna virus | 8 |
previously published | 8 |
income settings | 8 |
vaccine strategies | 8 |
theraflex uv | 8 |
pathogen density | 8 |
sample size | 8 |
side effects | 8 |
pathogen dynamics | 8 |
specific immune | 8 |
vapour pressure | 8 |
social defeat | 8 |
environmental protection | 8 |
may require | 8 |
viral entry | 8 |
borne pathogen | 8 |
population dynamics | 8 |
ventilation systems | 8 |
pathogenic contamination | 8 |
large numbers | 8 |
acute infectious | 8 |
surveillance efforts | 8 |
acute infection | 8 |
spatial genetic | 8 |
coli nissle | 8 |
protozoan pathogens | 8 |
animal host | 8 |
contaminated manure | 8 |
biosecurity practices | 8 |
pasteurella multocida | 8 |
microbial culture | 8 |
microbial diversity | 8 |
inflammatory activity | 8 |
genetic conflicts | 8 |
total coliform | 8 |
attenuated vaccine | 8 |
epidemiological data | 8 |
outbreaks associated | 8 |
geographic range | 8 |
root zone | 8 |
salicylic acid | 8 |
acinetobacter baumannii | 8 |
also important | 8 |
novel vaccine | 8 |
infected cell | 8 |
south america | 8 |
see additional | 8 |
negative results | 8 |
zoonotic event | 8 |
south korea | 8 |
respiratory systems | 8 |
mycorrhizal fungi | 8 |
threat condition | 8 |
previous work | 8 |
first protein | 8 |
airborne human | 8 |
airborne influenza | 8 |
spike protein | 8 |
also used | 8 |
transmission route | 8 |
water supplies | 8 |
sample processing | 8 |
bacterial cell | 8 |
pneumonic plague | 8 |
inlet outlet | 8 |
studies conducted | 8 |
sars outbreak | 8 |
bacterial toxins | 8 |
surface flow | 8 |
infectious risk | 8 |
enteric viruses | 8 |
protection agency | 8 |
also called | 8 |
slightly higher | 8 |
supplementary material | 8 |
human clinical | 8 |
necrosis factor | 8 |
virulence genes | 8 |
dispersion patterns | 8 |
host plants | 8 |
health emergencies | 8 |
pollution exposure | 8 |
legionella pneumophila | 8 |
factors influencing | 8 |
evolutionary time | 8 |
clinical symptoms | 8 |
human papillomavirus | 8 |
maximum likelihood | 8 |
associated molecular | 8 |
modern world | 8 |
pathogens also | 8 |
various pathogens | 8 |
virus replication | 8 |
reverse transcriptase | 8 |
body temperature | 8 |
two decades | 8 |
condition without | 8 |
molecular dating | 8 |
provide evidence | 8 |
also observed | 8 |
disease complex | 8 |
study using | 8 |
microbiological safety | 8 |
experimental studies | 8 |
viable cells | 8 |
diarrheal deaths | 8 |
different levels | 8 |
stranded dna | 8 |
infected hosts | 8 |
pathogenic fungus | 8 |
parasite species | 8 |
moral disgust | 8 |
key role | 8 |
giardia lamblia | 8 |
first time | 8 |
early stages | 8 |
resistance gene | 8 |
recent work | 8 |
significantly higher | 8 |
useful tool | 8 |
associated pathogens | 8 |
pattern recognition | 8 |
pathogens including | 8 |
virus families | 8 |
memory cells | 8 |
critical review | 8 |
many different | 8 |
behavioral immune | 8 |
data integration | 8 |
based techniques | 8 |
free water | 8 |
participants also | 8 |
th cells | 8 |
disease symptoms | 8 |
diagnostic tests | 8 |
low ph | 8 |
class ii | 8 |
binding partners | 8 |
early detection | 8 |
host proteins | 8 |
certification program | 8 |
including bacteria | 8 |
producing escherichia | 8 |
negative pressure | 8 |
pathogen load | 8 |
tof ms | 8 |
virus discovery | 8 |
susceptible individuals | 8 |
transmit via | 8 |
pathogen studies | 8 |
inactivate pathogens | 8 |
alien species | 8 |
beneficial effects | 8 |
protective efficacy | 8 |
case studies | 8 |
opportunistic pathogen | 8 |
long time | 8 |
rabies virus | 8 |
immigrant targets | 8 |
landscape features | 8 |
healthy animals | 8 |
intestinal tract | 8 |
respiratory syndromes | 8 |
linked immunosorbent | 8 |
correlation coefficients | 8 |
animal contact | 8 |
epithelial cell | 8 |
genomic dna | 8 |
determine whether | 8 |
analysis reveals | 8 |
severe disease | 8 |
essential oil | 8 |
immune changes | 8 |
extracellular proteins | 8 |
binding protein | 8 |
virus vaccines | 8 |
limited number | 8 |
lactobacillus plantarum | 8 |
chronic disease | 8 |
recombinant dna | 8 |
acquired immunity | 8 |
nanopore sequencing | 8 |
small number | 8 |
newly emerging | 8 |
environmental risk | 8 |
beef calves | 8 |
recombinant vaccine | 8 |
hygienic safety | 8 |
transmission via | 8 |
microbial water | 8 |
biosecurity management | 8 |
cell activation | 8 |
decision support | 8 |
health impacts | 8 |
human cytomegalovirus | 8 |
child health | 8 |
bacterial communities | 8 |
resistance surfaces | 8 |
global distribution | 7 |
management strategies | 7 |
may occur | 7 |
eppi discovery | 7 |
action plan | 7 |
porous media | 7 |
specific antigen | 7 |
disease avoidance | 7 |
primary pathogens | 7 |
cell entry | 7 |
critical role | 7 |
air distribution | 7 |
simplex virus | 7 |
photochemically treated | 7 |
van der | 7 |
health concern | 7 |
important factor | 7 |
airborne infectious | 7 |
cell screens | 7 |
lessons learned | 7 |
genomic analysis | 7 |
range infections | 7 |
histocompatibility complex | 7 |
contaminated food | 7 |
pathogens without | 7 |
supporting information | 7 |
herpes viruses | 7 |
weight gain | 7 |
adverse environmental | 7 |
log reduction | 7 |
disease epidemiology | 7 |
vaccine immunogenicity | 7 |
may influence | 7 |
reproductive success | 7 |
target pathogens | 7 |
national surveillance | 7 |
oligonucleotide probes | 7 |
world monkeys | 7 |
great potential | 7 |
protective immunity | 7 |
transmission models | 7 |
molecular diagnostics | 7 |
water resources | 7 |
control condition | 7 |
ancestral environments | 7 |
per day | 7 |
biological factors | 7 |
horizontal subsurface | 7 |
better understand | 7 |
cerebrospinal fluid | 7 |
influenza vaccines | 7 |
primate host | 7 |
successive infection | 7 |
different species | 7 |
vaccination program | 7 |
bipolar disorder | 7 |
poliovirus type | 7 |
parainfluenza virus | 7 |
confer protection | 7 |
dead cells | 7 |
highly variable | 7 |
higher pathogen | 7 |
reemerging species | 7 |
microbial genomics | 7 |
stool samples | 7 |
photochemical inactivation | 7 |
sample preparation | 7 |
exposure science | 7 |
now available | 7 |
wastewater using | 7 |
digestive tract | 7 |
animal reservoir | 7 |
relatively high | 7 |
human activities | 7 |
pathogens cause | 7 |
pathogen will | 7 |
vaccine approaches | 7 |
mechanisms underlying | 7 |
water systems | 7 |
health approach | 7 |
published maps | 7 |
see table | 7 |
pathogen antigens | 7 |
quorum sensing | 7 |
laboratory counts | 7 |
diarrheal disease | 7 |
priority list | 7 |
must also | 7 |
randomly assigned | 7 |
modified vaccinia | 7 |
gene transfer | 7 |
major impact | 7 |
air samples | 7 |
jurisdictional claims | 7 |
antigen delivery | 7 |
remains neutral | 7 |
enterica serotype | 7 |
inflammatory pathways | 7 |
superspreading events | 7 |
experimental data | 7 |
index method | 7 |
major challenge | 7 |
readily available | 7 |
new viruses | 7 |
respiratory illness | 7 |
waterborne disease | 7 |
genetic analysis | 7 |
food consumption | 7 |
ngs technologies | 7 |
give rise | 7 |
will lead | 7 |
fungi isolated | 7 |
wales hospital | 7 |
distribution systems | 7 |
low concentration | 7 |
new disease | 7 |
particulate matter | 7 |
disease states | 7 |
die autoren | 7 |
bacterial detection | 7 |
literature review | 7 |
pcr amplification | 7 |
transmitted via | 7 |
pathogen growth | 7 |
transmitted diseases | 7 |
clinically relevant | 7 |
human protein | 7 |
virus infections | 7 |
immune memory | 7 |
significantly increased | 7 |
descriptive statistics | 7 |
bacillus subtilis | 7 |
pathogen screening | 7 |
acid residues | 7 |
social media | 7 |
several advantages | 7 |
pestis genomes | 7 |
genomic era | 7 |
health experts | 7 |
either directly | 7 |
rural areas | 7 |
disease events | 7 |
intensive care | 7 |
plant host | 7 |
cell lines | 7 |
medicinal plants | 7 |
epidemic diseases | 7 |
transmission mechanism | 7 |
interaction networks | 7 |
bacterial proteins | 7 |
host contact | 7 |
social stress | 7 |
also provide | 7 |
sex differences | 7 |
health problems | 7 |
turkey poults | 7 |
direct detection | 7 |
cell membrane | 7 |
boundary conditions | 7 |
human rotavirus | 7 |
systems biology | 7 |
may serve | 7 |
genetic information | 7 |
higher spa | 7 |
leafy greens | 7 |
assessment methods | 7 |
horseshoe bats | 7 |
amended soils | 7 |
antiviral peptides | 7 |
potential sources | 7 |
social processes | 7 |
genomes reveal | 7 |
clinical presentation | 7 |
health research | 7 |
statistically different | 7 |
human dna | 7 |
calf pneumonia | 7 |
high degree | 7 |
indoor airborne | 7 |
growth factor | 7 |
institutional affiliations | 7 |
human exposure | 7 |
bacterial genome | 7 |
health effects | 7 |
may represent | 7 |
inhibitory receptor | 7 |
certification standards | 7 |
various types | 7 |
known pathogens | 7 |
species composition | 7 |
relatively small | 7 |
enterococcus faecium | 7 |
environmental surveillance | 7 |
also completed | 7 |
global surveillance | 7 |
southeast asia | 7 |
mediated immunity | 7 |
will depend | 7 |
external environment | 7 |
nosocomial infections | 7 |
sanitation intervention | 7 |
new approach | 7 |
potentially pathogenic | 7 |
respiratory organs | 7 |
versus host | 7 |
highly virulent | 7 |
viral load | 7 |
expert opinion | 7 |
also considered | 7 |
pathogen systems | 7 |
type i | 7 |
innate responses | 7 |
ebola epidemic | 7 |
social withdrawal | 7 |
positively associated | 7 |
host interaction | 7 |
contact networks | 7 |
well tolerated | 7 |
test results | 7 |
fecal bacteria | 7 |
riley model | 7 |
infection process | 7 |
molecular epidemiology | 7 |
virus outbreak | 7 |
dairy calves | 7 |
recently emerged | 7 |
also reported | 7 |
via direct | 7 |
springer nature | 7 |
major pathogen | 7 |
may include | 7 |
pathogenic attack | 7 |
multiple sclerosis | 7 |
carbon dioxide | 7 |
alfalfa sprouts | 7 |
nature remains | 7 |
fatty acids | 7 |
also shown | 7 |
working group | 7 |
given setting | 7 |
pressure units | 7 |
sequencing platforms | 7 |
strongly associated | 7 |
repeated social | 7 |
plant diseases | 7 |
evolutionary forces | 7 |
healthcare workers | 7 |
million deaths | 7 |
genetic methods | 7 |
proteins metabolites | 7 |
phytophthora infestans | 7 |
landscape epidemiology | 7 |
highly sensitive | 7 |
analysis results | 7 |
high diversity | 7 |
replication rates | 7 |
clinical studies | 7 |
also affect | 7 |
syndrome elevations | 7 |
like particles | 7 |
killer cells | 7 |
major histocompatibility | 7 |
root system | 7 |
two main | 7 |
eastern equine | 7 |
local infection | 7 |
probiotic strain | 7 |
composting process | 7 |
invasive species | 7 |
previous studies | 7 |
hoc networks | 7 |
pcr assays | 7 |
diarrheal diseases | 7 |
ventilation inlet | 7 |
large scale | 7 |
reproduction number | 7 |
year old | 7 |
phylogenetic tree | 7 |
disgust sensitivity | 7 |
indirect effect | 7 |
different mechanisms | 7 |
type iii | 7 |
may play | 7 |
cause illness | 7 |
fungal pathogenesis | 7 |
microbial genome | 7 |
data streams | 7 |
foodborne infections | 7 |
natural infections | 7 |
evidence suggests | 6 |
century ce | 6 |
take advantage | 6 |
particularly useful | 6 |
toxoplasma gondii | 6 |
may prove | 6 |
health needs | 6 |
positive results | 6 |
false positives | 6 |
across different | 6 |
gene segments | 6 |
chronic inflammatory | 6 |
hospital ward | 6 |
bacterial growth | 6 |
monopathogen patients | 6 |
sequencing data | 6 |
sd age | 6 |
health impact | 6 |
total coliforms | 6 |
national institute | 6 |
system function | 6 |
helminth eggs | 6 |
pathogen population | 6 |
lysogenic cycle | 6 |
hot spots | 6 |
many instances | 6 |
another way | 6 |
human parvovirus | 6 |
among patients | 6 |
extracellular environment | 6 |
first reported | 6 |
technology system | 6 |
microarray platform | 6 |
human history | 6 |
contagion risk | 6 |
phase response | 6 |
viruses may | 6 |
immune evasion | 6 |
cell walls | 6 |
detection limit | 6 |
will ultimately | 6 |
multiple host | 6 |
relative importance | 6 |
wellcome trust | 6 |
new antibiotics | 6 |
die inaktivierung | 6 |
several types | 6 |
specific detection | 6 |
health interventions | 6 |
disease dynamics | 6 |
health threat | 6 |
plant tissues | 6 |
bacterial disease | 6 |
antibody production | 6 |
antibody microarrays | 6 |
blood microbiome | 6 |
studies using | 6 |
temperature difference | 6 |
infection dynamics | 6 |
member states | 6 |
viral species | 6 |
environmental sample | 6 |
fecal streptococci | 6 |
laboratory methods | 6 |
achieved using | 6 |
several species | 6 |
derived antigens | 6 |
meteorological factors | 6 |
clinical characteristics | 6 |
data sources | 6 |
pathogenic infection | 6 |
first described | 6 |
cytokine production | 6 |
genetic relationships | 6 |
infect dis | 6 |
molecular diagnostic | 6 |
und der | 6 |
boltzmann method | 6 |
new technology | 6 |
host vector | 6 |
pharmacy data | 6 |
clinical data | 6 |
fruit trees | 6 |
new epidemic | 6 |
study provides | 6 |
transmitted helminth | 6 |
antimicrobial activities | 6 |
also contribute | 6 |
using host | 6 |
yet available | 6 |
will allow | 6 |
cfs patients | 6 |
human medicine | 6 |
evolutionary theory | 6 |
concentrates using | 6 |
severe diarrhea | 6 |
big data | 6 |
hospitalized patients | 6 |
infected people | 6 |
resonance biosensor | 6 |
respiratory droplets | 6 |
european centre | 6 |
human coronavirus | 6 |
species may | 6 |
biological agents | 6 |
risk factor | 6 |
national institutes | 6 |
develop novel | 6 |
drug product | 6 |
arms races | 6 |
respiratory virus | 6 |
modern approaches | 6 |
bacterial pneumonia | 6 |
uv light | 6 |
acute pathogen | 6 |
competitive exclusion | 6 |
immunology research | 6 |
evolutionary studies | 6 |
clinical use | 6 |
pathogen gene | 6 |
tk mit | 6 |
temperate zones | 6 |
incompletely understood | 6 |
false negative | 6 |
monocytogenes infection | 6 |
infections caused | 6 |
specific host | 6 |
protective antigens | 6 |
life cycles | 6 |
shifts will | 6 |
mycoplasma bovis | 6 |
waterborne outbreaks | 6 |
antifungal agents | 6 |
water safety | 6 |
ebola outbreak | 6 |
supplementary table | 6 |
neutralizing antibody | 6 |
democratic republic | 6 |
sampling methods | 6 |
serotype typhimurium | 6 |
amyloid beta | 6 |
emerging infections | 6 |
rapid diagnostics | 6 |
apheresis platelets | 6 |
sequencing approach | 6 |
transcription factors | 6 |
nucleotide polymorphism | 6 |
metagenomic detection | 6 |
increased inflammatory | 6 |
will provide | 6 |
reviews genetics | 6 |
flow wetlands | 6 |
isolation rooms | 6 |
plan view | 6 |
central role | 6 |
uv radiation | 6 |
depression risk | 6 |
metagenomic analysis | 6 |
reclaimed water | 6 |
significant risk | 6 |
proinflammatory cytokine | 6 |
precision epidemiology | 6 |
based vaccines | 6 |
landscape resistance | 6 |
energy conservation | 6 |
quantitative real | 6 |
evolved adaptively | 6 |
immunological memory | 6 |
microbiological contamination | 6 |
residential buildings | 6 |
gold surface | 6 |
zur inaktivierung | 6 |
particle size | 6 |
animal viruses | 6 |
sample sizes | 6 |
cell lysis | 6 |
transmission potential | 6 |
pathogens affecting | 6 |
ventilation rates | 6 |
typhimurium dt | 6 |
syndrome data | 6 |
additive solution | 6 |
recent review | 6 |
transmission rates | 6 |
pathogen levels | 6 |
studies reported | 6 |
bat species | 6 |
causative pathogen | 6 |
vaccines currently | 6 |
new endophytic | 6 |
manure application | 6 |
rates among | 6 |
electron microscopy | 6 |
risk analysis | 6 |
bacterial community | 6 |
buffy coat | 6 |
biocontrol potential | 6 |
new infectious | 6 |
genomic analyses | 6 |
first line | 6 |
become established | 6 |
close relatives | 6 |
der thrombozyten | 6 |
evolutionary perspective | 6 |
natural reservoir | 6 |
chronic symptoms | 6 |
probiotics also | 6 |
low sensitivity | 6 |
health genomics | 6 |
coagulation factors | 6 |
binding proteins | 6 |
host metabolism | 6 |
entry receptor | 6 |
test organisms | 6 |
species barrier | 6 |
saudi arabia | 6 |
disease virus | 6 |
health context | 6 |
theoretical work | 6 |
pathogens among | 6 |
vaccine antigen | 6 |
delivery system | 6 |
susceptibility testing | 6 |
emerging zoonoses | 6 |
new insights | 6 |
lavage fluid | 6 |
information regarding | 6 |
optical biosensors | 6 |
rotavirus vaccines | 6 |
near real | 6 |
swine fever | 6 |
treated wastewater | 6 |
human hosts | 6 |
cfd methods | 6 |
mycorrhizal fungus | 6 |
clinical syndromes | 6 |
therapeutic efficacy | 6 |
genetic variants | 6 |
antibodies present | 6 |
human adenovirus | 6 |
theme issue | 6 |
will facilitate | 6 |
resistance among | 6 |
two groups | 6 |
population densities | 6 |
seasonal variation | 6 |
biofilm formation | 6 |
high cost | 6 |
bioaerosol research | 6 |
phase ii | 6 |
east asia | 6 |
high potential | 6 |
endophytic streptomyces | 6 |
inflammatory cytokines | 6 |
animal feces | 6 |
molecular characterization | 6 |
mucociliary clearance | 6 |
child diarrhea | 6 |
restriction factors | 6 |
immunization schedule | 6 |
positive attitude | 6 |
conducted using | 6 |
strongly agree | 6 |
virulence management | 6 |
drug resistant | 6 |
pcr method | 6 |
associated virus | 6 |
simulation result | 6 |
novel pathogen | 6 |
machine learning | 6 |
food poisoning | 6 |
fermented milk | 6 |
influenza vaccine | 6 |
linear regression | 6 |
obligate pathogens | 6 |
different groups | 6 |
genetically modified | 6 |
ancient microbial | 6 |
west african | 6 |
white caucasian | 6 |
detected using | 6 |
high quality | 6 |
time polymerase | 6 |
protein complex | 6 |
water surface | 6 |
major pathogens | 6 |
hospital data | 6 |
specific antibodies | 6 |
vary widely | 6 |
controlled trials | 6 |
biomedical research | 6 |
microbial quality | 6 |
many factors | 6 |
control conditions | 6 |
pallidum subsp | 6 |
adverse effects | 6 |
many studies | 6 |
approaches used | 6 |
psychosocial stressors | 6 |
extremely high | 6 |
large population | 6 |
converting enzyme | 6 |
ecological factors | 6 |
wildlife disease | 6 |
bacterial diseases | 6 |
new tools | 6 |
pandemic potential | 6 |
particular pathogen | 6 |
provide information | 6 |
efflux pumps | 6 |
short time | 6 |
included participants | 6 |
online version | 6 |
vegetatively propagated | 6 |
human genes | 6 |
hand wipe | 6 |
tight junction | 6 |
brain tissue | 6 |
important consideration | 6 |
using genomics | 6 |
dna rna | 6 |
food animals | 6 |
genomic literacy | 6 |
respiratory secretions | 6 |
pathogenic microbes | 6 |
fecal indicators | 6 |
parasitic fitness | 6 |
fatty acid | 6 |
great promise | 6 |
seasonal patterns | 6 |
experimental methods | 6 |
pathogens found | 6 |
bed area | 6 |
average concentration | 6 |
dating analysis | 6 |
emergency department | 6 |
virus genome | 6 |
one important | 6 |
also include | 6 |
higher rates | 6 |
killer cell | 6 |
plants may | 6 |
patient management | 6 |
infections may | 6 |
two different | 6 |
aspergillus fumigatus | 6 |
also promote | 6 |
smallpox vaccine | 6 |
following infection | 6 |
exposure time | 6 |
professionals working | 6 |
many diseases | 6 |
african swine | 6 |
shelf life | 6 |
pathogen ecology | 6 |
pathogen richness | 6 |
using microarrays | 6 |
extracellular domain | 6 |
situational fluctuations | 6 |
i clinical | 6 |
phage therapy | 6 |
synergistic effect | 6 |
may need | 6 |
surface proteome | 6 |
efficacy data | 6 |
recognition receptors | 6 |
strongly disagree | 6 |
intermediate host | 6 |
oligonucleotide microarray | 6 |
body mass | 6 |
acute infections | 6 |
different strains | 6 |
wash interventions | 6 |
human gene | 6 |
antimicrobial therapy | 6 |
important issue | 6 |
shifts within | 6 |
epidemic models | 6 |
fecal source | 6 |
probiotics research | 6 |
final sample | 6 |
pathogens include | 6 |
metabolic pathways | 6 |
may well | 6 |
per year | 6 |
pathogenic organisms | 6 |
human herpesvirus | 6 |
unsteady flow | 6 |
digital disease | 6 |
data analysis | 6 |
production systems | 6 |
generally considered | 6 |
also increase | 6 |
proteins produced | 6 |
new strains | 6 |
animal origin | 6 |
information cycle | 6 |
rapid evolution | 6 |
klebsiella pneumoniae | 6 |
chlamydia pneumoniae | 6 |
becoming increasingly | 6 |
vitro antifungal | 6 |
ancient human | 6 |
process validation | 6 |
causes severe | 6 |
using molecular | 6 |
maternal depression | 6 |
water supply | 6 |
potential applications | 6 |
nature reviews | 6 |
statistically significant | 6 |
symptomatic individuals | 6 |
inflammatory activation | 6 |
evolutionary genetics | 6 |
high genetic | 6 |
endemic regions | 6 |
mycobacterium avium | 6 |
functional genomics | 6 |
conventional methods | 6 |
outer membrane | 6 |
targeted enrichment | 6 |
mannheimia haemolytica | 6 |
vaccine immunogens | 6 |
infected cases | 6 |
blood safety | 6 |
mycobacterium leprae | 6 |
secondary vehicles | 6 |
pathogen populations | 6 |
examine whether | 6 |
sars transmission | 6 |
across evolutionary | 6 |
environmental waters | 6 |
environmental reservoirs | 6 |
plague foci | 6 |
genetic purity | 6 |
open access | 6 |
often associated | 6 |
evolutionary relationships | 6 |
persisters formation | 6 |
adaptive evolution | 6 |
health system | 6 |
venezuelan equine | 6 |
associated proteins | 6 |
viral families | 6 |
binding sites | 6 |
inactivated vaccines | 6 |
pyrosequencing technology | 6 |
competent host | 6 |
host response | 6 |
virus removal | 6 |
test result | 6 |
diversity within | 6 |
salmonella senftenberg | 6 |
ventilation condition | 6 |
palm civets | 6 |
virus dna | 6 |
iii studies | 6 |
new diagnostic | 6 |
respiratory diseases | 6 |
different disciplines | 6 |
environmental media | 6 |
psychomotor slowing | 6 |
waste stabilization | 6 |
single virus | 6 |
geographical distribution | 6 |
host susceptibility | 6 |
water sample | 6 |
research needs | 6 |
biological element | 6 |
patho gen | 6 |
integrated approach | 6 |
aspergillus flavus | 6 |
across species | 6 |
current analysis | 6 |
confidence intervals | 5 |
available studies | 5 |
promising approach | 5 |
resident flora | 5 |
sandy soils | 5 |
blood group | 5 |
complex samples | 5 |
materials used | 5 |
pathogen life | 5 |
beef cattle | 5 |
several probiotics | 5 |
microbial forensics | 5 |
ligand masks | 5 |
virus ankara | 5 |
including many | 5 |
proteins encoded | 5 |
environmental enteric | 5 |
plague outbreak | 5 |
specific genes | 5 |
mouse model | 5 |
crucial role | 5 |
attitude towards | 5 |
envelope glycoprotein | 5 |
ground frost | 5 |
gas mask | 5 |
increased pathogen | 5 |
thermotolerant coliforms | 5 |
viral disease | 5 |
using whole | 5 |
fuel potential | 5 |
red squirrels | 5 |
exposed individuals | 5 |
exhaled breath | 5 |
disease severity | 5 |
human movement | 5 |
hiv vaccine | 5 |
low virulence | 5 |
built environment | 5 |
qualitative data | 5 |
biosecurity programs | 5 |
also provides | 5 |
dna polymerase | 5 |
genetic tools | 5 |
produce items | 5 |
ancient specimens | 5 |
nasal contamination | 5 |
treatment technologies | 5 |
improved exposure | 5 |
observed among | 5 |
clear prediction | 5 |
broad recognition | 5 |
resident microbiota | 5 |
occurs via | 5 |
ralstonia solanacearum | 5 |
vertebrate host | 5 |
avian flu | 5 |
alternative approaches | 5 |
biological processes | 5 |
cdna libraries | 5 |
human life | 5 |
identifying potential | 5 |
journal rstb | 5 |
animal hosts | 5 |
new methods | 5 |
surface area | 5 |
vbnc cells | 5 |
vaccine design | 5 |
dual infections | 5 |
lujo virus | 5 |
negative effects | 5 |
gut microflora | 5 |
small molecule | 5 |
alternative methods | 5 |
host ranges | 5 |
laboratory studies | 5 |
nucleotide polymorphisms | 5 |
hospital hygienists | 5 |
gill prasad | 5 |
severe infections | 5 |
bacterial virulence | 5 |
bacteria removal | 5 |
human interactions | 5 |
also may | 5 |
memory lymphocytes | 5 |
significantly reduces | 5 |
crossspecies transmission | 5 |
sars cases | 5 |
may vary | 5 |
pestis strains | 5 |
sentinel surveillance | 5 |
extracellular pathogen | 5 |
economic impact | 5 |
depression evolved | 5 |
large fraction | 5 |
enzymatic activity | 5 |
living organisms | 5 |
provide data | 5 |
using landscape | 5 |
measuring enteric | 5 |
animal markets | 5 |
national level | 5 |
results may | 5 |
pathogen characteristics | 5 |
intestinal microbiome | 5 |
based surveillance | 5 |
statistical significance | 5 |
temporal scales | 5 |
rstb phil | 5 |
molecular identification | 5 |
phylogenetic relationships | 5 |
propidium monoazide | 5 |
two major | 5 |
serious disease | 5 |
virulent viruses | 5 |
diverse range | 5 |
mit einer | 5 |
reference laboratories | 5 |
vaccine efforts | 5 |
additional factors | 5 |
agricultural soils | 5 |
plant disease | 5 |
recombinant protein | 5 |
face masks | 5 |
interacting partners | 5 |
comprehensive review | 5 |
inflammatory cytokine | 5 |
soil particles | 5 |
prevent infection | 5 |
western hemisphere | 5 |
evolving pathogens | 5 |
biologic decay | 5 |
target cells | 5 |
seed certification | 5 |
child growth | 5 |
plum pox | 5 |
active surveillance | 5 |
human enteric | 5 |
current research | 5 |
human virome | 5 |
recombinant vaccines | 5 |
irrigation systems | 5 |
exposure pathways | 5 |
emerging status | 5 |
diagnostic assay | 5 |
plant root | 5 |
different approaches | 5 |
contains supplementary | 5 |
health microbiology | 5 |
frozen plasma | 5 |
accepted article | 5 |
many enteric | 5 |
detecting pathogens | 5 |
diagnostic tools | 5 |
disease occurrence | 5 |
regulatory bodies | 5 |
participants rated | 5 |
defense response | 5 |
microbial dna | 5 |
novel host | 5 |
bacterial cells | 5 |
persistent pathogens | 5 |
physical barriers | 5 |
several pathogens | 5 |
data generated | 5 |
respective viral | 5 |
host mortality | 5 |
high phylogenetic | 5 |
infectious morbidity | 5 |
geographic location | 5 |
fungi associated | 5 |
multidrug efflux | 5 |
candidate vaccine | 5 |
bacterial dna | 5 |
novel virus | 5 |
short period | 5 |
currently exist | 5 |
pvd questionnaire | 5 |
disease prevalence | 5 |
international committee | 5 |
molecular detection | 5 |
vegetative propagation | 5 |
dust particles | 5 |
log vs | 5 |
circulating levels | 5 |
target population | 5 |
dissolved oxygen | 5 |
antimicrobial susceptibility | 5 |
coagulation factor | 5 |
surveillance network | 5 |
massively parallel | 5 |
general practice | 5 |
virus evolution | 5 |
study design | 5 |
vaccine will | 5 |
pythium aphanidermatum | 5 |
haemorrhagic fever | 5 |
scientific evidence | 5 |
internal measures | 5 |
lactobacillus delbrueckii | 5 |
health perspective | 5 |
autoimmune disease | 5 |
adenovirus type | 5 |
salmonella serotypes | 5 |
explained variance | 5 |
human intestinal | 5 |
tuberculosis infection | 5 |
respiratory activities | 5 |
technologies will | 5 |
adenovirus vector | 5 |
eppi networks | 5 |
potential risk | 5 |
sexual disgust | 5 |
animal exposure | 5 |
take place | 5 |
retention time | 5 |
blood system | 5 |
mediated immune | 5 |
petri plates | 5 |
high pathogen | 5 |
detection system | 5 |
salmonella typhi | 5 |
social avoidance | 5 |
studies also | 5 |
multicenter study | 5 |
virulent pathogens | 5 |
reference genome | 5 |
study participants | 5 |
widely utilized | 5 |
regression models | 5 |
disease development | 5 |
infection transmission | 5 |
cfs may | 5 |
reference databases | 5 |
current state | 5 |
human societies | 5 |
follow natural | 5 |
surveillance using | 5 |
highly connected | 5 |
produce cultivation | 5 |
rhamnosus gg | 5 |
primary care | 5 |
safety data | 5 |
human contact | 5 |
local level | 5 |
also essential | 5 |
ecosystem boundaries | 5 |
filter question | 5 |
inactivation system | 5 |
widespread use | 5 |
airborne contaminants | 5 |
virulence determinants | 5 |
homo sapiens | 5 |
research council | 5 |
microbiome may | 5 |
studies published | 5 |
using phage | 5 |
strong evidence | 5 |
epstein barr | 5 |
risk posed | 5 |
chemical exposure | 5 |
infectious mortality | 5 |
air velocity | 5 |
population genetics | 5 |
i studies | 5 |
transport systems | 5 |
substitutions per | 5 |
log units | 5 |
crop plants | 5 |
point scale | 5 |
effective vaccine | 5 |
monoclonal antibody | 5 |
deaths caused | 5 |
identifi cation | 5 |
health laboratories | 5 |
org journal | 5 |
particular concern | 5 |
significant evidence | 5 |
health management | 5 |
directly involved | 5 |
medical staff | 5 |
international travel | 5 |
pathogen recognition | 5 |
nutritional interventions | 5 |
existing vaccines | 5 |
chemical properties | 5 |
host dominance | 5 |
disease threats | 5 |
pathogens included | 5 |
environmental transmission | 5 |
pathogens listed | 5 |
authors highlight | 5 |
healthy adults | 5 |
located near | 5 |
precision medicine | 5 |
system inlet | 5 |
classified according | 5 |
important pathogens | 5 |
acquired immunodeficiency | 5 |
major cause | 5 |
microbial sequencing | 5 |
factors may | 5 |
spatial distribution | 5 |
environmental science | 5 |
butanoic acid | 5 |
genetic reassortment | 5 |
agricultural practices | 5 |
tissue damage | 5 |
mycobacterium bovis | 5 |
site models | 5 |
responses induced | 5 |
factor structure | 5 |
north american | 5 |
two broad | 5 |
person transmission | 5 |
last two | 5 |
antimicrobial drugs | 5 |
major epidemics | 5 |
virus detection | 5 |
nodulisporium sp | 5 |
resident strains | 5 |
cell surfaces | 5 |
hospital admission | 5 |
defi nitions | 5 |
clean water | 5 |
cause epidemics | 5 |
stabilization ponds | 5 |
amended soil | 5 |
children hospitalized | 5 |
helminth infection | 5 |
vesicular stomatitis | 5 |
high mortality | 5 |
data source | 5 |
infection will | 5 |
alternaria brassicicola | 5 |
host receptors | 5 |
major public | 5 |
labor intensive | 5 |
pathogens within | 5 |
disease incidence | 5 |
nutrient uptake | 5 |
environmental stress | 5 |
clinical outcomes | 5 |
community acquired | 5 |
technology pubs | 5 |
mirasol pathogen | 5 |
largely due | 5 |
shigella spp | 5 |
near future | 5 |
medical interventions | 5 |
foodborne illnesses | 5 |
genome data | 5 |
exposure data | 5 |
prior exposure | 5 |
conversion factor | 5 |
great importance | 5 |
unique infectious | 5 |
safety authority | 5 |
viral community | 5 |
immune mechanisms | 5 |
trypanosoma cruzi | 5 |
scientific community | 5 |
also found | 5 |
host specific | 5 |
based amplification | 5 |
indoor environment | 5 |
encoded proteins | 5 |
current knowledge | 5 |
host genome | 5 |
associated viruses | 5 |
may allow | 5 |
taking place | 5 |
host genetic | 5 |
susceptible animals | 5 |
induce depression | 5 |
multiple introductions | 5 |
biodiversity loss | 5 |
sample included | 5 |
increased expression | 5 |
lytic phage | 5 |
induced immune | 5 |
effective method | 5 |
may act | 5 |
certain pathogens | 5 |
acidic conditions | 5 |
low temperatures | 5 |
surveillance purposes | 5 |
human transmissible | 5 |
clinical development | 5 |
three different | 5 |
compared using | 5 |
der pi | 5 |
protein synthesis | 5 |
landscape variables | 5 |
identified using | 5 |
amotosalen hcl | 5 |
microbial metabolites | 5 |
phytosanitary measures | 5 |
development process | 5 |
mycoplasma spp | 5 |
higher proportion | 5 |
past several | 5 |
rapid clinical | 5 |
climatic conditions | 5 |
subsurface wetlands | 5 |
study showed | 5 |
untersuchungen zur | 5 |
alpha treatment | 5 |
genome annotation | 5 |
using data | 5 |
cause human | 5 |
single pathogen | 5 |
relationships among | 5 |
cause severe | 5 |
clinical laboratories | 5 |
related diseases | 5 |
human microbes | 5 |
among pathogens | 5 |
routine laboratory | 5 |
host community | 5 |
also demonstrated | 5 |
absenteeism data | 5 |
coli strains | 5 |
singapore military | 5 |
within populations | 5 |
previously identified | 5 |
dna probes | 5 |
related compounds | 5 |
driven selection | 5 |
immunosorbent assay | 5 |
virulence antigen | 5 |
directly related | 5 |
another important | 5 |
also increased | 5 |
identify pathogens | 5 |
smallpox eradication | 5 |
several factors | 5 |
faecal contamination | 5 |
main driver | 5 |
expression systems | 5 |
food products | 5 |
pathogens acquired | 5 |
infectious cause | 5 |
see ref | 5 |
genetic changes | 5 |
chain fatty | 5 |
infected humans | 5 |
airborne particle | 5 |
without partitions | 5 |
conservation biology | 5 |
mycelial growth | 5 |
replicating pathogen | 5 |
mainly include | 5 |
resource settings | 5 |
molecular biologists | 5 |
infected patients | 5 |
distribution system | 5 |
like illness | 5 |
blood stream | 5 |
sexual activity | 5 |
reporting system | 5 |
control group | 5 |
novel bioactive | 5 |
social desirability | 5 |
improved ventilation | 5 |
gene therapy | 5 |
bacillus cereus | 5 |
last resort | 5 |
electrical signal | 5 |
contributed content | 5 |
culture results | 5 |
viral proteins | 5 |